Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (63) 63
graft rejection - immunology (38) 38
male (35) 35
transplantation (35) 35
index medicus (32) 32
adult (31) 31
female (31) 31
middle aged (31) 31
hla antigens - immunology (28) 28
surgery (24) 24
immunology (22) 22
isoantibodies - blood (22) 22
graft survival (21) 21
graft rejection - prevention & control (20) 20
risk factors (20) 20
retrospective studies (19) 19
immunosuppressive agents - therapeutic use (17) 17
kidney transplantation (17) 17
time factors (17) 17
treatment outcome (17) 17
bortezomib (16) 16
histocompatibility testing (16) 16
antibodies (15) 15
kidney transplantation - immunology (15) 15
aged (14) 14
alloantibodies (14) 14
boronic acids - therapeutic use (14) 14
pyrazines - therapeutic use (14) 14
isoantibodies - immunology (13) 13
tissue donors (13) 13
transplantation, homologous (12) 12
donor-specific antibodies (11) 11
young adult (11) 11
adolescent (10) 10
follow-up studies (10) 10
graft rejection (10) 10
human leukocyte antigen (10) 10
immunosuppression (10) 10
protease inhibitors - therapeutic use (10) 10
antibody-mediated rejection (9) 9
kaplan-meier estimate (9) 9
plasmapheresis (9) 9
allograft survival (8) 8
analysis (8) 8
biopsy (8) 8
histocompatibility (8) 8
hla antibodies (8) 8
organ transplant recipients (8) 8
rejection (8) 8
transplants & implants (8) 8
kidney transplantation - adverse effects (7) 7
mediated rejection (7) 7
organ transplantation (7) 7
risk (7) 7
united states - epidemiology (7) 7
allergy and immunology (6) 6
child (6) 6
failure (6) 6
graft rejection - epidemiology (6) 6
graft survival - immunology (6) 6
histocompatibility antigens (6) 6
hla histocompatibility antigens (6) 6
immunoglobulin g - blood (6) 6
incidence (6) 6
kidney (6) 6
kidney-transplantation (6) 6
organ transplantation - adverse effects (6) 6
plasma-cells (6) 6
proportional hazards models (6) 6
risk assessment (6) 6
therapy (6) 6
transplantation of organs, tissues, etc (6) 6
viral antibodies (6) 6
age distribution (5) 5
alloantibody (5) 5
allografts (5) 5
biomarkers - blood (5) 5
chronic rejection (5) 5
diagnosis (5) 5
graft rejection - diagnosis (5) 5
histocompatibility antigen hla (5) 5
hla-specific antibodies (5) 5
immunoglobulin g (5) 5
immunoglobulin g - immunology (5) 5
immunosuppressive agents - adverse effects (5) 5
liver (5) 5
living donors (5) 5
monitoring, immunologic (5) 5
outcomes (5) 5
pathology (5) 5
psychiatry (5) 5
recipients (5) 5
registries (5) 5
transplantation tolerance (5) 5
abridged index medicus (4) 4
anti-hla antibodies (4) 4
antibody specificity (4) 4
apoptosis (4) 4
creatinine - blood (4) 4
desensitization (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Pediatric intestinal transplantation: Analysis of the intestinal transplant registry
by Raghu, Vikram K and Beaumont, Jennifer L and Everly, Matthew J and Venick, Robert S and Lacaille, Florence and Mazariegos, George V
Pediatric Transplantation, ISSN 1397-3142, 12/2019, Volume 23, Issue 8, p. n/a
The ITR serves as an international database for centers around the world to contribute to current knowledge about intestinal transplant outcomes. Led by the... 
graft rejection | pediatric transplantation | registries | intestinal transplantation | short bowel syndrome | pediatrics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Cytokines as Biomarkers for Renal Transplant Recipients: What is New?
by Kawakita, Satoru and Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2016, Volume 32, pp. 23 - 30
Poor long-term graft survival remains a major problem in the field of organ transplantation. This could be attributed at least in part, to the lack of reliable... 
kidney | graft rejection | cytokines | chemokines | transplantation | Immunosuppression | Cytokines | Humans | Biomarkers | Graft Rejection | Graft Survival | Kidney Transplantation
Journal Article
Details down arrow
3. Donor-Specific HLA Antibodies: A Review of Data Published in 2016
by Idica, Adam and Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2016, Volume 32, pp. 13 - 22
The results from continued research regarding the role of anti-human leukocyte antigen (anti-HLA) antibodies and donor-specific antibodies (DSA) in... 
donor-specific antibodies | allograft rejection | transplantation | Humans | Antibodies | Graft Rejection | Graft Survival | Kidney Transplantation | HLA Antigens | Isoantibodies | Tissue Donors | Transplantation, Homologous
Journal Article
Details down arrow
4. Update on Alloantibodies in Solid Organ Transplantation
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2014, pp. 125 - 129
In the last few years, there have been studies published on serial testing and longitudinal analysis of anti-human leukocyte antigen (anti-HLA) antibodies. The... 
Liver Transplantation | Graft Rejection - prevention & control | Humans | Risk Factors | HLA Antigens - immunology | Graft Survival | Treatment Outcome | Biomarkers - blood | Lung Transplantation - adverse effects | Isoantibodies - blood | Immunity, Humoral | Time Factors | Graft Rejection - immunology | Histocompatibility | Pancreas Transplantation - adverse effects | Kidney Transplantation - adverse effects
Journal Article
Details down arrow
5. An Update on Cardiac Transplantation in the United States
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2014, pp. 27 - 32
Heart transplantation in the United States remains an important option for those with heart failure. Survival rates over the last 25 years have improved with... 
Heart Failure - surgery | Predictive Value of Tests | United States - epidemiology | Heart Transplantation - trends | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Infant | Male | Young Adult | Time Factors | Aged, 80 and over | Adult | Female | Registries | Heart Failure - diagnosis | Child | Heart Transplantation - mortality | Heart Failure - mortality | Histocompatibility Testing | Graft Rejection - prevention & control | Risk Factors | Kaplan-Meier Estimate | Heart Transplantation - adverse effects | Treatment Outcome | Tissue and Organ Procurement - organization & administration | Tissue and Organ Procurement - trends | Adolescent | Aged | Graft Rejection - immunology | Graft Survival - drug effects | Histocompatibility
Journal Article
Details down arrow
6. There is a Road, No Simple Highway: Envisioning a Path to Better Long-Term Organ Transplant Survival
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2015, Volume 31, p. 203
The current half-life of a transplanted organ has not improved in a very long time. Historical reports on the causes of allograft failure have pointed to a... 
Journal Article
Details down arrow
7. A summary of bortezomib use in transplantation across 29 centers
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2009, pp. 323 - 337
Despite the substantial effects and promise of bortezomib-based regimens, there is still much to be learned. Finding an effective approach to removing... 
Graft Rejection - drug therapy | Bortezomib | Heart Transplantation - immunology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Combined Modality Therapy | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Plasmapheresis | Immunoglobulins, Intravenous - therapeutic use | Lung Transplantation - immunology | Antilymphocyte Serum - therapeutic use | Adult | Female | Aged | Graft Rejection - immunology | Safety | Kidney Transplantation - immunology | Protease Inhibitors - therapeutic use
Journal Article
Details down arrow
8. Alloantibodies in Organ Transplant: A Review of Data Published in 2015
by Maehara, Curtis and Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2015, Volume 31, p. 139
In recent years, there have been multiple studies published on longitudinal and retrospective analysis of anti-human leukocyte antigen (anti-HLA) antibodies.... 
Journal Article
Details down arrow
9. Incidence and hazards of alloantibodies in renal transplantation
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2013, pp. 313 - 317
In the last 10 years, many reports on the impact of antibodies against human leukocyte antigens (HLA) have been published. Now, in 2014, the overwhelming... 
Antibody Specificity | Graft Rejection - epidemiology | Graft Rejection - prevention & control | Humans | HLA Antigens - immunology | Isoantibodies - immunology | Seroepidemiologic Studies | Graft Rejection - immunology | Kidney Transplantation - statistics & numerical data | Incidence
Journal Article
Details down arrow
10. An Update on Cardiac Transplantation in the United States Based on an Analysis of the UNOS Registry
by Khatiwala, Juhi R and Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2015, Volume 31, p. 27
Cardiac transplantation remains a viable option for those with end-stage heart disease. In the last few years, the number of heart transplants has begun to... 
Journal Article
Details down arrow
11. Immunosuppression regimens to address alloantibodies in transplant recipients
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2012, pp. 219 - 223
The purpose of immunosuppression in patients receiving a solid organ transplant is to prevent both acute and chronic rejection, while avoiding the... 
Graft Rejection - drug therapy | Transplantation Immunology - immunology | Humans | Immunosuppressive Agents - therapeutic use | Transplantation Immunology - drug effects | Isoantibodies - immunology | Organ Transplantation
Journal Article
Details down arrow
12. Understanding and addressing the humoral immune response in transplant recipients
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2012, p. 225
Transplantation Immunology - immunology | Immunity, Humoral - immunology | Humans | Organ Transplantation
Journal Article
Details down arrow
13. Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry
by Cheng, Elaine Y and Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2014, pp. 13 - 26
Advances in immunosuppression (IS) agents and strategies have resulted in reduced rejection rates and improved survival outcomes after liver transplantation.... 
United States - epidemiology | Immunosuppression - trends | Liver Transplantation - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Liver Transplantation - trends | Immunosuppression - mortality | Immunosuppression - adverse effects | Time Factors | Graft Rejection - mortality | Adult | Female | Registries | Retrospective Studies | Graft Rejection - prevention & control | Risk Factors | Liver Transplantation - mortality | Treatment Outcome | Tissue and Organ Procurement - organization & administration | Disease-Free Survival | Tissue and Organ Procurement - trends | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Graft Survival - drug effects
Journal Article
Details down arrow
14. Full Text Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients
: Hepatology
by Jucaud, Vadim and Shaked, Abraham and DesMarais, Michele and Sayre, Peter and Feng, Sandy and Levitsky, Josh and Everly, Matthew J
Hepatology, ISSN 0270-9139, 03/2019, Volume 69, Issue 3, pp. 1273 - 1286
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Understanding trends and predictors of outcome in elderly renal transplant recipients: an analysis of the UNOS registry
by Dieplinger, Georg and Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2013, pp. 1 - 11
The continuously growing number of patients of advanced age with end-stage renal disease demands adequate treatment in the form of renal transplantation.... 
Kidney Failure, Chronic - mortality | Predictive Value of Tests | United States - epidemiology | Age Distribution | Kidney Failure, Chronic - surgery | Humans | Middle Aged | Risk Factors | Graft Survival | Male | Registries - statistics & numerical data | Aged, 80 and over | Adult | Female | Kidney Transplantation - mortality | Aged | Retrospective Studies
Journal Article
Details down arrow
16. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2011, pp. 319 - 325
Based on our knowledge that donor specific anti-HLA antibodies (DSA) are a major cause of allograft loss, determining how to monitor patients for DSA and how... 
Histocompatibility Testing | Graft Rejection - prevention & control | Humans | Immunosuppressive Agents - therapeutic use | Monitoring, Immunologic | HLA Antigens - immunology | Graft Survival | Treatment Outcome | Evidence-Based Medicine | Transplantation Tolerance - drug effects | Isoantibodies - blood | Histocompatibility - drug effects | Time Factors | Organ Transplantation - adverse effects | Graft Rejection - immunology | Desensitization, Immunologic
Journal Article
Details down arrow
17. Full Text Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection
by Everly, Matthew J and Everly, Jason J and Susskind, Brian and Brailey, Paul and Arend, Lois J and Alloway, Rita R and Roy-Chaudhury, Prabir and Govil, Amit and Mogilishetty, Gautham and Rike, Adele H and Cardi, Michael and Wadih, George and Tevar, Amit and Woodle, E. Steve
Transplantation, ISSN 0041-1337, 12/2008, Volume 86, Issue 12, pp. 1754 - 1761
Background. Current antihumoral therapies in transplantation and autoimmune disease do not target the mature antibody-producing plasma cell. Bortezomib is a... 
B cell | Alloantibodies | Bortezomib | Proteasome inhibitor | Plasma cell | SURGERY | APOPTOSIS | ACTIVATION | DENDRITIC CELLS | PHASE-2 | IMMUNOLOGY | MULTIPLE-MYELOMA CELLS | REVERSAL | TRANSPLANTATION | RENAL-ALLOGRAFT REJECTION | REFRACTORY MYELOMA | PROTEASOME INHIBITOR BORTEZOMIB | FK-506 | Acute Disease | Kidney Transplantation - pathology | United States | Graft Rejection - prevention & control | Humans | Immunosuppressive Agents - therapeutic use | Boronic Acids - adverse effects | Pyrazines - therapeutic use | Thrombocytopenia - chemically induced | Boronic Acids - therapeutic use | Isoantibodies - blood | Kidney Transplantation - physiology | Biopsy | Pyrazines - adverse effects | Creatinine - blood | Isoantibodies - immunology | Protease Inhibitors - adverse effects | Immunosuppressive Agents - adverse effects | Kidney Transplantation - immunology | Protease Inhibitors - therapeutic use | Paresthesia - chemically induced | United States Food and Drug Administration | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Heart transplantation in an aging society: an analysis of 25 years of the OPTN/UNOS registry
by Hörmann, Mareike and Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2013, pp. 31 - 44
The annual number of adult heart transplantations in the United States is still low due to a lack of donor organs. Median long-term survival has been improved... 
Heart Failure - surgery | Heart-Assist Devices - statistics & numerical data | United States - epidemiology | Age Distribution | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Graft Survival | Male | Young Adult | Registries - statistics & numerical data | Adolescent | Aging | Adult | Female | Aged | Heart Transplantation - mortality | Heart Failure - mortality
Journal Article
Details down arrow
19. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients
by Everly, Matthew J
Clinical transplants, ISSN 0890-9016, 2011, pp. 333 - 336
This section of Clinical Transplants 2011 has presented outcomes-based evidence that supports the use of single antigen bead testing for detection of donor... 
Histocompatibility Testing | Graft Rejection - prevention & control | Humans | Monitoring, Immunologic | HLA Antigens - immunology | Graft Survival | Treatment Outcome | Evidence-Based Medicine | Isoantibodies - blood | Transplantation Tolerance | Time Factors | Organ Transplantation - adverse effects | Graft Rejection - immunology | Histocompatibility
Journal Article
Details down arrow
20. Full Text Incidence and impact of de Novo donor-specific alloantibody in primary renal allografts
by Everly, Matthew J and Rebellato, Lorita M and Haisch, Carl E and Ozawa, Miyuki and Parker, Karen and Briley, Kimberly P and Catrou, Paul G and Bolin, Paul and Kendrick, William T and Kendrick, Scott A and Harland, Robert C and Terasaki, Paul I
Transplantation, ISSN 0041-1337, 02/2013, Volume 95, Issue 3, pp. 410 - 417
Background. To date, limited information is available describing the incidence and impact of de novo donor-specific anti-human leukocyte antigen (HLA)... 
Allograft survival | Donor-specific antibodies | Epidemiology | Human leukocyte antigen | SURVIVAL | SURGERY | HLA-SPECIFIC ANTIBODIES | POSTTRANSPLANT | INJURY | PROSPECTIVE TRIAL | GRAFT FAILURE | IMMUNOLOGY | TRANSPLANTATION | HUMAN-LEUKOCYTE ANTIGEN | KIDNEY-TRANSPLANT FAILURE | ANTIBODY-MEDIATED REJECTION | ASSOCIATION | Follow-Up Studies | Histocompatibility Testing | Humans | Middle Aged | HLA Antigens - immunology | Male | Transplantation, Homologous | Incidence | Isoantibodies - blood | Young Adult | Graft Rejection - epidemiology | Time Factors | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Graft Rejection - immunology | Tissue Donors | Kidney Transplantation - immunology | Longitudinal Studies | Antibodies | Clinical trials | Alloantibodies | Histocompatibility antigen HLA | Leukocytes | Kidney transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.